SCHEMBL23804013

SCHEMBL23804013

Nc1ccc(-c2ccc(OCCNC(=O)O)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP3 P08254 2/20 0.50
▸ NPC1 O15118 5/20 0.49
▸ MAPK1 P28482 2/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ USP2 O75604 1/20 0.49
▸ ALOX15 P16050 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ MTNR1A P48039 2/20 0.49
▸ MTNR1B P49286 2/20 0.49
▸ ALDH1A1 P00352 4/20 0.48
▸ HPGD P15428 2/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ TP53 P04637 1/20 0.48
▸ RAB9A P51151 2/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7094090 0.95 MTNR1A (0.53) NPC1MAPK1HSD17B10USP2ALOX15
SCHEMBL17821174 0.90 L3MBTL1 (0.54) NPC1MAPK1HSD17B10USP2ALOX15
SCHEMBL25349904 0.86 APP (0.51) NPC1MAPK1HSD17B10USP2ALOX15
SCHEMBL25232048 0.85 ALDH1A1 (0.49) NPC1MAPK1HSD17B10USP2ALOX15
SCHEMBL15939818 0.83 MTNR1A (0.53) MMP3NPC1MAPK1HSD17B10USP2
SCHEMBL21099911 0.81 MTNR1A (0.51) MMP3NPC1MAPK1HSD17B10USP2
SCHEMBL10354336 0.80 MTNR1A (0.73) NPC1MAPK1HSD17B10USP2ALOX15
SCHEMBL23817033 0.80 CA12 (0.67) MMP3MTNR1AMTNR1B
SCHEMBL21595955 0.80 NPC1 (0.73) NPC1MAPK1HSD17B10USP2ALOX15
SCHEMBL25268396 0.80 DRD4 (0.57) NPC1MAPK1HSD17B10USP2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4103566-A1 FUSED PYRIMIDINE COMPOUNDS AS KCC2 MODULATORS AstraZeneca AB (SE) 2022-12-21 — — EP disclosed
WO-2021180952-A1 FUSED PYRIMIDINE COMPOUNDS AS KCC2 ASTRAZENECA AB (SE) 2021-09-16 — — WO disclosed
Send feedback